An estimated 2.6million people already use weight-loss drugs to tackle stubborn fat.
Last month, a new pill form of Wegovy – the blockbuster slimming jab – was approved for use in the UK in what has been hailed as a game-changing moment for obesity treatment.
Take-up is expected to be huge, with studies suggesting people are twice as likely to opt for a tablet as an injection.
Yet for some, the results can be underwhelming, while others are reluctant to rely on medication at all.
Now experts say a little-known ingredient – known as Amarasate – could offer an alternative, naturally stimulating appetite-suppressing hormones
To provide well-rounded coverage and a breadth of insight across various events, we rely on contributions from several staff writers, each bringing their own area of expertise to our publication.
